MedPath

A study to find out the prognostic indicator of acute pancreatitis.

Not yet recruiting
Conditions
Acute pancreatitis, unspecified,
Registration Number
CTRI/2024/08/072055
Lead Sponsor
Dr Harsh Singh Yadav
Brief Summary

This study will classify patients according to Atlanta classification then will calculate the BISAP and APACHE 2 of enrolled patients with serum amylase, lipase, CRP , LDH and correlation of biochemical markers with scoring system is done.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Patient diagnosed with acute pancreatitis clinically, biochemical and radiologically.

Exclusion Criteria
  • Patient with age less than 18 or more than 80yrs.
  • Known co-morbidities other than diabetes and hypertension.
  • Pregnant women.
  • Any malignancy.
  • H/o tuberculosis H/o COVID-19 Recurrent pancreatitis Chronic Pancreatitis Any upper abdominal surgery.
  • Patient not willing to follow up.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To determine the correlation of serum amylase lipase with BISAP and APACHE 2 in the patients of acute pancreatitis2 weeks and 6 weeks
Secondary Outcome Measures
NameTimeMethod
To know the better prognosis predictor in patients of acute pancreatitis2 weeks & 6 week

Trial Locations

Locations (1)

Uttar Pradesh University of medical science saifai Etawah

🇮🇳

Etawah, UTTAR PRADESH, India

Uttar Pradesh University of medical science saifai Etawah
🇮🇳Etawah, UTTAR PRADESH, India
Dr Harsh Singh yadav
Principal investigator
9112556214
doctorharshsinghyadav@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.